Delivery Order SPE2DB20D1109-SPE2DB24FM97M
- Not listed
- This federal contract award is for the delivery of Vyvanse 50 mg capsules to the U.S. government. The $1,116.46 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of...
- This federal contract award is for the delivery of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,372.34, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a broader Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
- This federal contract award is for the delivery of Vyvanse 50 mg capsules to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,402.14, is a delivery order placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for...
- This federal contract award is for the delivery of Vyvanse 20 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,688.04, is a delivery order awarded under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 and runs through November 2026. This IDC serves as the primary...
- This federal contract award is for the delivery of Vyvanse capsules, a specialty pharmaceutical medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The $9,552.93 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a child contract under its parent company Cencora, Inc. The contract has an ultimate completion date of January 18, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award is for the delivery of Vyvanse 60 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract, valued at $1,906.31, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- The federal contract award is for the delivery of Vyvanse 70 mg capsules, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,824.95, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued...
- This federal contract award is for the delivery of Vyvanse capsules (40mg) to the Defense Logistics Agency (DLA), a defense agency. The $34,466.34 firm-fixed-price delivery order contract has a period of performance through May 28, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and was awarded through open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999.00...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,594.94 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. (doing business as Amerisourcebergen) holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award is for the delivery of Vyvanse 70 mg capsules to the U.S. Department of Defense, specifically the Medical Supply Chain of the Defense Logistics Agency (DLA) Troop Support. The $1,749.56 fixed-price delivery order was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB24FM97MDelivery Order
This federal contract award is for the delivery of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,795.76, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a broader Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veterans' healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 10/25/23 |